je.st
news
Tag: do
TechnoVision 2015 - What Would Amazon Do?
2014-11-08 16:50:04| Capgemini News Feed
Ron Tolido Language Worldwide Share: Share this page
Tags: do
amazon
technovision
Should The SEC Ask What Would Blackstone Do?
2014-10-28 03:03:33| Railroads - Topix.net
The Securities and Exchange Commission recently trumpeted its enforcement successes for its 2014 fiscal year. For an agency dedicated to full disclosure, there were some notable omissions, including: A New York federal jury verdict finding hedge fund manager Nelson Obus and his co-defendants innocent of insider trading; A Chicago federal jury verdict finding that an Illinois farmer and his three sons innocent of insider trading in Florida East Coast Industries, Inc. securities; Note that all of these losses occurred in an Article III court and 80% of them occurred after a jury trial.
Tags: do
would
sec
blackstone
Environmentalists don't like Europe's new climate plan. Can Obama do better?
2014-10-25 16:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Mother Jones: Environmental groups are warning that a new European agreement to slash greenhouse gas emissions by 40 percent by 2030 sets the bar far too low. The pact--which was reached early Friday in Brussels--makes the European Union the first major bloc of countries to commit to emissions targets ahead of next year's crucial climate change talks in Paris. At the Paris meeting, world leaders will attempt to hammer out a global agreement that will keep warming below 2 degrees Celsius (3.6 degrees Fahrenheit)....
Editor's Viewpoint - Diageo's Haig Club: And, What Do You Do?
2014-10-07 17:31:00| Daily beverage news and comment - from just-drinks.com
I'm not entirely sure why so many trade press column inches were given over to the latest 'news' from Diageo's new single grain Scotch whisky brand, Haig Club, yesterday. I mean, the launch of the product was initially announced six months ago.
Can Gilead Sciences Be A Do-Gooder And Still Do Well?
2014-09-27 15:18:50| Biotech - Topix.net
The top management of Wall Street highflier Gilead Sciences is facing a challenge that confronts many companies that have flourished but face the criticism that they need to give back to the global community in more direct ways. The fundamental question boils down to this: Can a company do well by doing good, for the sake of the world, and still do well - for its demanding stockholders? It's a major issue, as Gilead Science's stock has climbed about 40% so far this year, on the wings of the highly successful drug Sovaldi, which combats hepatitis C. The drug carries an enormous price tag of $1,000 per pill under a 12-week regimen that typically costs $84,000.
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »